2-18fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: A retrospective validation of the sempet trial

M. Bachner, Y. Loriot, M. Gross-goupil, P. A. Zucali, A. Horwich, J. R. Germa-lluch, C. Kollmannsberger, F. Stoiber, A. Fléchon, K. Oechsle, S. Gillessen, J. Oldenburg, G. Cohn-cedermark, G. Daugaard, F. Morelli, A. Sella, S. Harland, M. Kerst, J. Gampe, C. DittrichK. Fizazi, M. De Santis*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of '2-18fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: A retrospective validation of the sempet trial'. Together they form a unique fingerprint.

Medicine & Life Sciences